Osaka, Japan

Satoshi Yonishi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Satoshi Yonishi: Advancements in Pharmaceutical Patents

Introduction: Satoshi Yonishi is a renowned inventor based in Osaka, Japan, who has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative treatments for various neurological and psychological conditions, Yonishi's work exemplifies the vital role that inventors play in advancing medical science.

Latest Patents: Satoshi Yonishi holds a patent for "Pyrazine derivatives and pharmaceutical use thereof". This patented pyrazine derivative exhibits properties as an adenosine antagonist, proving useful in the prevention and treatment of several health conditions including depression, dementia, Parkinson’s disease, anxiety, pain, cerebrovascular disease, and heart failure. The patent outlines the specific biochemical formula of the pyrazine compound, demonstrating its potential in the pharmaceutical industry.

Career Highlights: Currently affiliated with Astellas Pharma GmbH, Satoshi Yonishi has dedicated his career to the research and development of innovative therapeutic solutions. His work is characterized by a commitment to improving patient outcomes through the advancement of drug treatments.

Collaborations: Throughout his career, Satoshi has collaborated with notable colleagues such as Satoshi Aoki and Yuji Matsushima. This teamwork reflects the importance of collaboration in advancing medical research and developing effective pharmaceutical solutions. Together, they leverage their expertise to foster groundbreaking innovations in healthcare.

Conclusion: Satoshi Yonishi's contributions as an inventor underscore the crucial intersection of innovation and healthcare. With his patent on pyrazine derivatives, he is poised to make a lasting impact on the treatment of serious medical conditions. Yonishi, alongside his talented colleagues at Astellas Pharma GmbH, continues to inspire the future of medicinal advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…